Rosemary A Crane's Net Worth

$3.85 Million

Estimate Recalculated Nov 7, 2024 12:17PM EST

Who is Rosemary A Crane?

Rosemary A Crane has an estimated net worth of $3.85 Million. This is based on reported shares across multiple companies, which include Catalent, Inc., Targanta Therapeutics Corp., Tarsus Pharmaceuticals, Inc., TEVA PHARMACEUTICAL INDUSTRIES LTD, Edge Therapeutics, Inc., MELA SCIENCES, INC. /NY, Certara, Inc., Unilife Corp, and EPOCRATES INC.

SEC CIK

Rosemary A Crane's CIK is 0001443343

Past Insider Trading and Trends

2023 was Rosemary A Crane's most active year for acquiring shares with 8 total transactions. Rosemary A Crane's most active month to acquire stocks was the month of May. 2023 was Rosemary A Crane's most active year for disposing of shares, totalling 3 transactions. Rosemary A Crane's most active month to dispose stocks was the month of May. 2014 saw Rosemary A Crane paying a total of $50,001.80 for 67,570 shares, this is the most they've acquired in one year. In 2024 Rosemary A Crane cashed out on 33,121 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Catalent, Inc. (CTLT) Snapshot price: $60.01

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+41.43%
6.99K
—
—
23.87K
Oct 27
Form 4
+32.59%
4.15K
—
—
16.88K
Oct 27
Form 4
+12.38%
1.4K
—
—
12.73K
Oct 28
Form 4
+23.09%
2.13K
—
—
11.33K
Oct 29
Form 4
+7.74%
661
—
—
9.2K
Aug 27
Form 4
+58.91%
3.17K
—
—
8.54K
Aug 22
Form 4
+350.63%
4.18K
—
—
5.38K
Aug 23
Form 3
—
0
—
—
0
No matching records found

Targanta Therapeutics Corp. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 25
Form 3
—
0
—
—
0
No matching records found

Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $30.59

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+167.50%
3.35K
—
—
5.35K
Jun 24
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 22
Form 4
∞
2K
—
—
2K
Jun 16
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Aug 11
Form 3
—
0
—
—
0
No matching records found

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Snapshot price: $18.06

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+25.58%
21.11K
—
—
103.61K
Jun 15
Form 4
—
0
—
—
0
Jun 6
Form 4
+23.70%
15.81K
—
—
82.51K
Aug 4
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Aug 4
Form 4
+27.73%
14.48K
—
—
66.7K
Jun 14
Form 3
—
0
—
—
0
No matching records found

Edge Therapeutics, Inc. (PDSB) Snapshot price: $2.91

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
10K
—
—
10K
Mar 15
Form 4
—
0
—
—
0
Aug 14
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Sep 18
Form 3
—
0
—
—
0
No matching records found